Monashee Investment Management »

Alpine Immune Sciences shares owned by Monashee Investment Management

Quarter-by-quarter ownership of Alpine Immune Sciences (ALPN) shares owned by Monashee Investment Management from 13F filings

Historical chart of Monashee Investment Management investment in Alpine Immune Sciences

Tip: Access up to 7 years of quarterly data

All positions including Alpine Immune Sciences held by Monashee Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alpine Immune Sciences by Monashee Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $964k 75k 12.89
2022-09-30 $720k 100k 7.20
2021-03-31 $107k 30k 3.61
2020-12-31 $76k 30k 2.56
2020-09-30 $4.0k 30k 0.13

More positions owned by Monashee Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Index Fds Total Stk Mkt (VTI)
Structure Therapeutics Sponsored Ads (GPCR)
Aercap Holdings Nv SHS (AER)
PG&E Corporation (PCG)
Korro Bio (KRRO)
Eyepoint Pharmaceuticals Com New (EYPT)
Celldex Therapeutics Com New (CLDX)
Roivant Sciences SHS (ROIV)

View all positions for Monashee Investment Management

Top funds holding Alpine Immune Sciences

Decheng Capital
RA Capital Management
Lynx1 Capital Management
Dr. Jeffrey R. Jay, M.D.
Paradigm Biocapital Advisors
Frazier Life Sciences Management
Cormorant Asset Management
OrbiMed Advisors
Vanguard Group
T. Rowe Price Associates
Commodore Capital
Octagon Capital Advisors
Franklin Resources
Citadel Advisors
Henderson Group

View all funds holding Alpine Immune Sciences